{"id":"https://openalex.org/W4408934039","doi":"https://doi.org/10.1158/2767-9764.28688364","title":"Supplementary Figure 4 from A Kinome-Wide Synthetic Lethal CRISPR/Cas9 Screen Reveals That mTOR Inhibition Prevents Adaptive Resistance to CDK4/CDK6 Blockade in HNSCC","display_name":"Supplementary Figure 4 from A Kinome-Wide Synthetic Lethal CRISPR/Cas9 Screen Reveals That mTOR Inhibition Prevents Adaptive Resistance to CDK4/CDK6 Blockade in HNSCC","publication_year":2025,"publication_date":"2025-03-28","ids":{"openalex":"https://openalex.org/W4408934039","doi":"https://doi.org/10.1158/2767-9764.28688364"},"language":"en","primary_location":{"id":"doi:10.1158/2767-9764.28688364","doi":"https://doi.org/10.1158/2767-9764.28688364","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2767-9764.28688364","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/2767-9764.28688364","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5087813362","display_name":"Yusuke Goto","orcid":"https://orcid.org/0000-0001-7720-9740","observed_orcids":["https://orcid.org/0000-0001-7720-9740"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yusuke Goto","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7720-9740","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044864291","display_name":"Keiichi Koshizuka","orcid":"https://orcid.org/0000-0002-0431-8337","observed_orcids":["https://orcid.org/0000-0002-0431-8337"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Keiichi Koshizuka","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-0431-8337","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043752699","display_name":"Toshinori Ando","orcid":"https://orcid.org/0000-0002-3141-8173","observed_orcids":["https://orcid.org/0000-0002-3141-8173"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Toshinori Ando","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-3141-8173","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005405732","display_name":"Hiroki Izumi","orcid":"https://orcid.org/0000-0002-9566-4859","observed_orcids":["https://orcid.org/0000-0002-9566-4859"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hiroki Izumi","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9566-4859","affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Xingyu Wu","orcid":"https://orcid.org/0000-0001-9289-7115","observed_orcids":["https://orcid.org/0000-0001-9289-7115"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xingyu Wu","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9289-7115","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009239010","display_name":"Kuniaki Sato","orcid":"https://orcid.org/0000-0001-6014-1911","observed_orcids":["https://orcid.org/0000-0001-6014-1911"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kuniaki Sato","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-6014-1911","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068361265","display_name":"Tomohiko Ishikawa","orcid":"https://orcid.org/0000-0003-3115-0047","observed_orcids":["https://orcid.org/0000-0003-3115-0047"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tomohiko Ishikawa","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-3115-0047","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026067532","display_name":"Kyle M. Ford","orcid":"https://orcid.org/0000-0002-9944-9216","observed_orcids":["https://orcid.org/0000-0002-9944-9216"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kyle Ford","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9944-9216","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020631342","display_name":"Xiaodong Feng","orcid":"https://orcid.org/0000-0002-2741-5420","observed_orcids":["https://orcid.org/0000-0002-2741-5420"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xiaodong Feng","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-2741-5420","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074012583","display_name":"Zhiyong Wang","orcid":"https://orcid.org/0009-0004-2761-9871","observed_orcids":["https://orcid.org/0009-0004-2761-9871"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zhiyong Wang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0004-2761-9871","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026625543","display_name":"Nadia Arang","orcid":"https://orcid.org/0000-0002-8167-2188","observed_orcids":["https://orcid.org/0000-0002-8167-2188"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nadia Arang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-8167-2188","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048560164","display_name":"Michael M. Allevato","orcid":"https://orcid.org/0000-0003-1846-7189","observed_orcids":["https://orcid.org/0000-0003-1846-7189"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael M. Allevato","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-1846-7189","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103056679","display_name":"Ayush Kishore","orcid":"https://orcid.org/0009-0000-7367-3212","observed_orcids":["https://orcid.org/0009-0000-7367-3212"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ayush Kishore","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0000-7367-3212","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102747646","display_name":"Prashant Mali","orcid":"https://orcid.org/0000-0002-3383-1287","observed_orcids":["https://orcid.org/0000-0002-3383-1287"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Prashant Mali","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-3383-1287","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5038753309","display_name":"Jorge Silvio Gutkind","orcid":"https://orcid.org/0000-0002-5150-4482","observed_orcids":["https://orcid.org/0000-0002-5150-4482"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. Silvio Gutkind","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-5150-4482","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.8105000257492065,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.8105000257492065,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.07109999656677246,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10307","display_name":"Head and Neck Cancer Studies","score":0.04019999876618385,"subfield":{"id":"https://openalex.org/subfields/2733","display_name":"Otorhinolaryngology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mtor-inhibition","display_name":"mTOR inhibition","score":0.9169999957084656},{"id":"https://openalex.org/keywords/adaptive-resistance","display_name":"adaptive resistance","score":0.7820000052452087},{"id":"https://openalex.org/keywords/head-and-neck-squamous-cell-carcinoma","display_name":"head and neck squamous cell carcinoma","score":0.9120000004768372},{"id":"https://openalex.org/keywords/ink128","display_name":"INK128","score":0.902999997138977},{"id":"https://openalex.org/keywords/palbociclib","display_name":"palbociclib","score":0.9980000257492065},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.9409999847412109},{"id":"https://openalex.org/keywords/xenografts","display_name":"xenografts","score":0.7509999871253967},{"id":"https://openalex.org/keywords/synthetic-lethality","display_name":"synthetic lethality","score":0.652999997138977},{"id":"https://openalex.org/keywords/crispr-cas9-screening","display_name":"CRISPR-Cas9 screen","score":0.9039999842643738}],"concepts":[{"id":"https://openalex.org/C54174078","wikidata":"https://www.wikidata.org/wiki/Q3197188","display_name":"Kinome","level":3,"score":0.859600305557251},{"id":"https://openalex.org/C98108389","wikidata":"https://www.wikidata.org/wiki/Q412563","display_name":"CRISPR","level":3,"score":0.8434876203536987},{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.6520851850509644},{"id":"https://openalex.org/C199649820","wikidata":"https://www.wikidata.org/wiki/Q14911762","display_name":"Cyclin-dependent kinase 6","level":5,"score":0.5668696165084839},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.5618293285369873},{"id":"https://openalex.org/C132455925","wikidata":"https://www.wikidata.org/wiki/Q16965677","display_name":"Cas9","level":4,"score":0.44859376549720764},{"id":"https://openalex.org/C26207810","wikidata":"https://www.wikidata.org/wiki/Q1134884","display_name":"Pleiotropy","level":4,"score":0.4260373115539551},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.377057820558548},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.34206870198249817},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.23630449175834656},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.1611863374710083},{"id":"https://openalex.org/C124320809","wikidata":"https://www.wikidata.org/wiki/Q46292","display_name":"Cyclin-dependent kinase","level":4,"score":0.16082265973091125},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.12895268201828003},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.11410883069038391},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.1135496199131012},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.10945278406143188},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.09497720003128052},{"id":"https://openalex.org/C127716648","wikidata":"https://www.wikidata.org/wiki/Q104053","display_name":"Phenotype","level":3,"score":0.07288050651550293},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.06553861498832703}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/2767-9764.28688364","doi":"https://doi.org/10.1158/2767-9764.28688364","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2767-9764.28688364","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/28688364","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Figure_4_from_A_Kinome-Wide_Synthetic_Lethal_CRISPR_Cas9_Screen_Reveals_That_mTOR_Inhibition_Prevents_Adaptive_Resistance_to_CDK4_CDK6_Blockade_in_HNSCC/28688364","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/2767-9764.28688364","doi":"https://doi.org/10.1158/2767-9764.28688364","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2767-9764.28688364","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3081777379","https://openalex.org/W2615218473","https://openalex.org/W3040709352","https://openalex.org/W2977624170","https://openalex.org/W4394740655","https://openalex.org/W2605577322","https://openalex.org/W2615346513","https://openalex.org/W4307138640","https://openalex.org/W4366132770","https://openalex.org/W4311501380"],"abstract_inverted_index":{"Combination":[0],"therapy":[1],"with":[2],"INK128":[3],"and":[4],"palbociclib":[5],"is":[6],"effective":[7],"against":[8],"HNSCC":[9],"xenograft":[10]},"counts_by_year":[],"updated_date":"2026-09-27T08:07:27.782135","created_date":"2025-10-10T00:00:00"}